Zero's number comes from section 9 of quarterly cashflow report and it's 2.1 million. Around 700k of the cost is development.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025